USPTO serial 79134009
GENETHON BIOPROD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 10, 2014
- Examiner
- WILSON, MARYNELLE WEST
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GENETHON BIOPROD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
GENETHON - Association régie par la loi du 1er juillet 1901
F-91000 Evry, FR
Other trademarks owned by GENETHON - Association régie par la loi du 1er juillet 1901
GENETHON -; Association régie par la loi du; 1er juillet 1901
FR
Other trademarks owned by GENETHON -; Association régie par la loi du; 1er juillet 1901
GENETHON -; Association régie par la loi du; 1er juillet 1901
FR
Other trademarks owned by GENETHON -; Association régie par la loi du; 1er juillet 1901
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janet G Ricciuti
Janet G Ricciuti JANET GILBERT RICCIUTI, PC1830 S Street, NWWashington, DC 20009UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, veterinary and sanitary products, namely, gene and cell therapy products for the treatment of rare diseases; chemical preparations for medical and pharmaceutical use or for veterinary use, namely, gene and cell therapy products for the treatment of rare diseases; biological preparations for medical and pharmaceutical use or for veterinary use, namely, gene and cell therapy products for the treatment of rare diseases; enzyme preparations for medical and pharmaceutical use or for veterinary use; microorganism cultures for medical and pharmaceutical use or for veterinary use; culture media for bacteriology; nutritive substances for microorganisms for research and development of gene and cell therapy products used in the treatment of rare diseases; preparations of micro-organisms, of genetically modified organisms and of cells for medical and pharmaceutical use or for veterinary use, particularly for gene therapy and cell therapy; compounds acting on genetic or other pathologies, in human beings and animals, particularly on muscle and neuromuscular diseases, diseases of the immune system, cardiovascular diseases, dermatological diseases, diseases of the central and peripheral nervous system, cancers, asthma, allergies, lipid disorders, obesity and diabetes and infectious diseases; kits for preparing cells or for selecting biologically active compounds for medical, biomedical, chemical, genetic, pharmaceutical or veterinary use; diagnostic preparations, reagents and media for medical, biomedical, chemical, genetic, pharmaceutical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology; sanitary preparations for medical use | SECTION 71 - CANCELLED | — |
| 042 | Pharmaceutical research; research for the discovery of new medicines; scientific research, particularly in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; basic and applied research in the field of gene and cell therapy; technical research in the field of gene and cell therapy; sorting and selection of molecules for use in gene and cell therapy; development and validation of biological tests, cellular tests and genetic tests; activities in functional genomics for identifying, characterizing, validating or developing biologically active molecules; surveying engineering work; technical project study in the field of gene and cell therapy; professional consultancy unrelated to business operations in the field of scientific research and therapies; research and development of new pharmaceutical products for others | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GENETHON - Association régie par la loi du 1er juillet 1901
- Other trademarks owned by GENETHON -; Association régie par la loi du; 1er juillet 1901
- Other trademarks owned by GENETHON -; Association régie par la loi du; 1er juillet 1901
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named GENETHON BIOPROD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 17, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Dec 17, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 2, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 14, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Nov 14, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Jun 10, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 5, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 4, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 4, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 10, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 10, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 25, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 25, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 21, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 5, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 5, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 5, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 19, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 19, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jan 31, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 31, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 31, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 16, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2013 | CRSN | CORRECTION SENT TO IB | — |
| Oct 18, 2013 | CRCR | CORRECTION CREATED FOR IB | — |
| Oct 8, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 16, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 13, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 12, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 12, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |